🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

‘Advancing Engineered T-Cell Therapies for Breast Cancer’ A shoutout to Valentina Hoyos Velez, MD for the insightful presentation at our Work In Progress Seminar. Curious to hear your views: Which will make the leap in breast cancer cancer treatment first, TCR-T or CAR-T cells? #Immunotherapy

🇨🇴🇨🇴🇨🇴

Very happy to see our case published at Annals of Internal Medicine: Clinical Cases Facultad de Medicina - Universidad de los Andes Fundación Santa Fe de Bogotá Universidad El Bosque 🇨🇴

Proud brother! One step closer!!

Happy Pride Month! Diversity drives scientific breakthroughs - well said Lee Grimes Lab. #Pride2024 🏳️‍🌈 ❤️🧡💛💚💙💜

Original Article: Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy nej.md/3Rln392 Editorial: T-Cell Cancer after CAR T-Cell Therapy nej.md/3z5UYft #Hematology

Beyond grateful to the NYP/Cornell benign hematology service for an incredible month of learning and clinical experience. And thanks to Alexandra Gomez A. for this amazing opportunity! #Match2025

Gracias a ATENEA y Alcaldía de Bogotá por la invitación! La educación es y será la mejor inversión social!

Jose Rafael Espinosa Secretaría de Educación de Bogotá Víctor Saavedra Isabel Segovia O Carlos F. Galán Alcaldía de Bogotá Diego Fernando Chamorro Ortiz Uniandes Diego Duque Secretaría Distrital de Integración Social Universidad Nacional de Colombia 🌟 Retomamos con la cuarta y última conferencia en los #PremiosJóvenesALaE con la ingeniera Diana Trujillo, directora de vuelo del Centro Espacial Johnson de la NASA. ¡Una colombiana que brilla en el espacio! Conéctate ya aquí: youtube.com/live/MSeE_a3Kg… #BogotáMiCiudadMiCasa

Another great study run by Translational Breast Cancer Research Consortium and lead by my dear colleague Julie Nangia at Dan L Duncan Comprehensive Cancer Center. 042 used Ruxolitinib for 10-20 days b4 surgery to inhibit pSTAT5 pathway in premalig AH/CIS (ductal/lobular). 1ry endpoint is apoptosis by Caspase3 drop pending #SABCS24 #bcsm

👀“Tunneling” CARs! New manuscript from Stacey Van Pelt from the Omer lab #biorxiv on how transgenic expression of osteopontin improves infiltration of GD2.CARs into dense tumors and boosts tumor control. A step forward in optimizing cell therapies for solid tumors!

📄Real-world characteristics and outcomes of ERBB2-mutant NSCLC in Latin American patients (CLICaP) out in The Oncologist Amazing work Andres F. Cardona Erick Saldanha, MD academic.oup.com/oncolo/article…

Proud to share this amazing collaborative effort reporting the largest cohort to date on LATAM patients with ERBB2-mutant NSCLC. Thanks to this amazing team of authors!! Vladmir C. Cordeiro de Lima, MD, PhD Marcelo Corassa, MD. Gil-Santana Helano Freitas Aline Fares Andres F. Cardona Diego F. Chamorro

Excited to have contributed to this amazing work led by the incredible Lauren Somes from the Valentina Hoyos Velez, MD lab! ZP4: A novel target for CAR-T cell therapy in triple negative breast cancer. sciencedirect.com/science/articl…

International Medical Graduates Are Integral to the Delivery of Patient Care in the United States ⁦Annals of Int Med⁩ acpjournals.org/doi/10.7326/AN…

Two Colombians elected as AACR Fellows! 🇨🇴 Dr. Pelayo Correa, recognized for his pioneering work in gastric carcinogenesis, and Dr. Nubia Muñoz, honored for her research on the link between HPV and cervical cancer.

I’m thrilled to share that I’ve matched into Internal Medicine at Pitt General Internal Medicine Grateful to everyone who supported me throughout this journey. Endless thanks to Valentina Hoyos Velez, MD, John M. González and Andres F. Cardona -my mentors. Can’t wait to follow in Ilias Christodoulou footsteps!

If you're at #AACR25, don’t miss this amazing work led by Andrés Mosquera from the Valentina Hoyos Velez, MD lab. We're tackling HLA downregulation in solid tumors using TCR-engineered γδ T cells!

🔬"Approaches to target solid tumors and the tumor microenvironment with adoptive T cell therapies." Thank you Katie McKenna Ph.D. Katie McKenna, PhD for sharing your work with us! What approaches have you found effective in targeting solid tumors?📝